ES512533A0 - Un procedimiento para la preparacion de 1-(3-halo-2-piridinil)piperazinas. - Google Patents

Un procedimiento para la preparacion de 1-(3-halo-2-piridinil)piperazinas.

Info

Publication number
ES512533A0
ES512533A0 ES512533A ES512533A ES512533A0 ES 512533 A0 ES512533 A0 ES 512533A0 ES 512533 A ES512533 A ES 512533A ES 512533 A ES512533 A ES 512533A ES 512533 A0 ES512533 A0 ES 512533A0
Authority
ES
Spain
Prior art keywords
halo
piridinil
piperazines
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES512533A
Other languages
English (en)
Other versions
ES8306740A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES8306740A1 publication Critical patent/ES8306740A1/es
Publication of ES512533A0 publication Critical patent/ES512533A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES512533A 1981-05-26 1982-05-25 Un procedimiento para la preparacion de 1-(3-halo-2-piridinil)piperazinas. Granted ES512533A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26712081A 1981-05-26 1981-05-26

Publications (2)

Publication Number Publication Date
ES8306740A1 ES8306740A1 (es) 1983-06-01
ES512533A0 true ES512533A0 (es) 1983-06-01

Family

ID=23017399

Family Applications (4)

Application Number Title Priority Date Filing Date
ES512533A Granted ES512533A0 (es) 1981-05-26 1982-05-25 Un procedimiento para la preparacion de 1-(3-halo-2-piridinil)piperazinas.
ES519854A Expired ES8403475A1 (es) 1981-05-26 1983-02-16 Un procedimiento para la preparacion de 1-(3-halo-2-piridinil) piperazinas.
ES519855A Granted ES519855A0 (es) 1981-05-26 1983-02-16 Un procedimiento para la preparacion de 1-(3-halo-2-piridinil) piperazinas.
ES519856A Granted ES519856A0 (es) 1981-05-26 1983-02-16 Un procedimiento para la preparacion de 1-(3-halo-2-piridinil) piperazinas.

Family Applications After (3)

Application Number Title Priority Date Filing Date
ES519854A Expired ES8403475A1 (es) 1981-05-26 1983-02-16 Un procedimiento para la preparacion de 1-(3-halo-2-piridinil) piperazinas.
ES519855A Granted ES519855A0 (es) 1981-05-26 1983-02-16 Un procedimiento para la preparacion de 1-(3-halo-2-piridinil) piperazinas.
ES519856A Granted ES519856A0 (es) 1981-05-26 1983-02-16 Un procedimiento para la preparacion de 1-(3-halo-2-piridinil) piperazinas.

Country Status (17)

Country Link
EP (1) EP0065757B1 (es)
JP (1) JPS6055068B2 (es)
AT (1) ATE11134T1 (es)
AU (1) AU547319B2 (es)
CA (1) CA1214467A (es)
DE (1) DE3261827D1 (es)
DK (1) DK234282A (es)
ES (4) ES512533A0 (es)
FI (1) FI821739A7 (es)
GR (1) GR76413B (es)
IE (1) IE53035B1 (es)
IL (1) IL65802A (es)
NO (1) NO821730L (es)
NZ (1) NZ200642A (es)
PH (1) PH18686A (es)
PT (1) PT74926B (es)
ZA (1) ZA823611B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH056685U (ja) * 1991-07-09 1993-01-29 株式会社ユアサコーポレーシヨン 電池の艤装構造
US20040152710A1 (en) * 2002-10-15 2004-08-05 Deecher Darlene Coleman Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms
US7345096B2 (en) 2002-10-15 2008-03-18 Wyeth Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms
US7531543B2 (en) 2003-10-14 2009-05-12 Wyeth Phenylpiperazine cycloalkanol derivatives and methods of their use
US7365076B2 (en) 2003-10-14 2008-04-29 Wyeth Substituted aryl cycloalkanol derivatives and methods of their use
US7550485B2 (en) 2003-10-14 2009-06-23 Wyeth Substituted N-heterocycle derivatives and methods of their use
US7402698B2 (en) 2003-10-14 2008-07-22 Wyeth Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use
US7524846B2 (en) 2003-10-14 2009-04-28 Wyeth Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use
US7491723B2 (en) 2003-10-14 2009-02-17 Wyeth Alkanol and cycloalkanol-amine derivatives and methods of their use
US7419980B2 (en) 2003-10-14 2008-09-02 Wyeth Fused-aryl and heteroaryl derivatives and methods of their use
US7517899B2 (en) 2004-03-30 2009-04-14 Wyeth Phenylaminopropanol derivatives and methods of their use
US7414052B2 (en) 2004-03-30 2008-08-19 Wyeth Phenylaminopropanol derivatives and methods of their use
CN101671297B (zh) * 2008-09-11 2012-05-09 上海药明康德新药开发有限公司 4-(3-碘-2-吡啶基)哌嗪类化合物的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773951A (en) * 1972-12-21 1973-11-20 Miles Lab Method of treating depression with 1-(2-pyridyl)piperazine
US4078063A (en) * 1976-09-24 1978-03-07 Merck & Co., Inc. Piperazinylpyridines

Also Published As

Publication number Publication date
DK234282A (da) 1982-11-27
PH18686A (en) 1985-08-29
IL65802A (en) 1985-12-31
NZ200642A (en) 1984-11-09
EP0065757B1 (en) 1985-01-09
FI821739A7 (fi) 1982-11-27
CA1214467A (en) 1986-11-25
PT74926A (en) 1982-06-01
IE821225L (en) 1982-11-26
IE53035B1 (en) 1988-05-11
ES8403476A1 (es) 1984-03-16
AU8380282A (en) 1982-12-02
ES519855A0 (es) 1984-03-16
ATE11134T1 (de) 1985-01-15
GR76413B (es) 1984-08-10
JPS584766A (ja) 1983-01-11
IL65802A0 (en) 1982-08-31
EP0065757A1 (en) 1982-12-01
ES519854A0 (es) 1984-03-16
ES8403477A1 (es) 1984-03-16
DE3261827D1 (en) 1985-02-21
ES8403475A1 (es) 1984-03-16
ES8306740A1 (es) 1983-06-01
JPS6055068B2 (ja) 1985-12-03
ZA823611B (en) 1983-12-28
ES519856A0 (es) 1984-03-16
PT74926B (en) 1985-05-16
NO821730L (no) 1982-11-29
AU547319B2 (en) 1985-10-17
FI821739A0 (fi) 1982-05-17

Similar Documents

Publication Publication Date Title
ES2170211T3 (es) Compuestos azaheterociclicos que tienen actividad antagonista de los receptores de taquiquinina; nk1 y nk2.
BG43007A3 (en) Method for preparing n- (bicyclo- hetero- cyclyl)- 4- piperidinamines
ES542322A0 (es) Un procedimiento para la preparacion de derivados de la 2 pirimidinil-1-piperazina
ES519856A0 (es) Un procedimiento para la preparacion de 1-(3-halo-2-piridinil) piperazinas.
ES524945A0 (es) Un procedimiento para la preparacion de 1-(4-(4,4-dialquil-2,6-piperidindion-1-il)butil)piperazinas.
ES549513A0 (es) Procedimiento para la obtencion de agentes dispersantes hi- drosolubles para composiciones acuosas pigmentadas
ES522037A0 (es) Procedimiento para preparar derivados de piperazina.
MX162676A (es) Procedimiento para la preparacion de derivados de 2-(piridilalquensulfinii.)benzimidazoles n-substituidos
ES506583A0 (es) Procedimiento para la preparacion de derivados de isoquino- leina
ES539799A0 (es) Un procedimiento para la preparacion de hexahidro-arilquinolizinas sustituidas.
AR227542A1 (es) Procedimiento para preparar derivados de 4-(4-amino-6,7-dimetoxi-quinazolin-2-il)-1-(2,4-dioxo-2,2,3,4-tetrahidro-pirimidin-6-il)-piperazina
MX162047A (es) Procedimiento para producir compuestos de imidazolina 1,2-substituida
SE8302979D0 (sv) Piperazine derivatives, their production and pharmaceutical compositions containing them
ES2081834T3 (es) Pirrolidin-2-onas 4-metil y 4-etil sustituidas.
DK163783A (da) Fremgangsmaade til fremstilling af imidazolinderivater
ES8601173A1 (es) Procedimiento para preparar la n-(3-trifluorometilfenil)-n'-propargil-piperazina
ES551110A0 (es) Procedimiento para la obtencion de derivados de 1-(2,4-diclorofenil)-2-(1-imidazolil)etanol
SU1297421A1 (ru) ГИДРОХЛОРИДЫ 3-ЗАМЕЩЕННЫХ 2-ЭТИЛ-4-МЕТИЛПИРАЗОЛО(1,5-а)-БЕНЗИМИДАЗОЛА, ОБЛАДАЮЩИЕ АНТИАРИТМИЧЕСКОЙ АКТИВНОСТЬЮ
ES538784A0 (es) Procedimiento para obtencion del maleato 1-(n-((s)-1-etoxicarbonil-3-fenilpropil)-l-alanil)-l-prolina
IT1209952B (it) Spalmatrice rapida di collante per tutti i tipi di pavimentazione
ES526207A0 (es) Un procedimiento para la preparacion de 4-(4-(2-ar-2-(1h-azol-1-il-metil)-1,3-dioxolan-4-il-metoxi)fenil)piperazina